These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22812695)

  • 21. Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2.
    Xia B; Lin M; Dong W; Chen H; Li B; Zhang X; Hou Y; Lou G
    J Biochem Mol Toxicol; 2018 Aug; 32(8):e22168. PubMed ID: 30004169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells.
    Miyamoto M; Sawada K; Nakamura K; Yoshimura A; Ishida K; Kobayashi M; Shimizu A; Yamamoto M; Kodama M; Hashimoto K; Kimura T
    Sci Rep; 2020 Oct; 10(1):16755. PubMed ID: 33028939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance.
    Ye G; Fu G; Cui S; Zhao S; Bernaudo S; Bai Y; Ding Y; Zhang Y; Yang BB; Peng C
    J Cell Sci; 2011 Feb; 124(Pt 3):359-68. PubMed ID: 21224400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of GRP78 in the Resistance of Ovarian Carcinoma Cells to Paclitaxel.
    Zhang LY; Li PL; Xu A; Zhang XC
    Asian Pac J Cancer Prev; 2015; 16(8):3517-22. PubMed ID: 25921171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.
    Horio M; Kato T; Mii S; Enomoto A; Asai M; Asai N; Murakumo Y; Shibata K; Kikkawa F; Takahashi M
    Cancer Med; 2012 Oct; 1(2):218-29. PubMed ID: 23342271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.
    Janczar S; Nautiyal J; Xiao Y; Curry E; Sun M; Zanini E; Paige AJ; Gabra H
    Cell Death Dis; 2017 Jul; 8(7):e2955. PubMed ID: 28749468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.
    Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells.
    Xu H; Gao H; Li H; Li D; Yuan W; Zhang L; Cheng P; Su X; Li Z; Wang G; Zhang T
    Mol Med Rep; 2020 Oct; 22(4):2966-2972. PubMed ID: 32945387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
    Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
    J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.
    Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P
    Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and epithelial ovarian cancer therapeutics.
    Patel S; Kumar L; Singh N
    Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.
    Liu X; Gao Y; Shen J; Yang W; Choy E; Mankin H; Hornicek FJ; Duan Z
    Mol Cancer Ther; 2016 Jul; 15(7):1691-701. PubMed ID: 27207777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
    Eoh KJ; Lee SH; Kim HJ; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    Biochem Biophys Res Commun; 2018 Mar; 497(2):513-520. PubMed ID: 29452092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells.
    Wendler A; Keller D; Albrecht C; Peluso JJ; Wehling M
    Oncol Rep; 2011 Jan; 25(1):273-9. PubMed ID: 21109987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
    Wu K; Yang Y; Zhao J; Zhao S
    Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.
    Zhang M; Liu S; Fu C; Wang X; Zhang M; Liu G; Dai C; Gong Z; Xu H; Fu Z; Xu P; Xu J; Jia X
    Cancer Biother Radiopharm; 2019 Jun; 34(5):316-324. PubMed ID: 30892073
    [No Abstract]   [Full Text] [Related]  

  • 40. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
    Yang N; Kaur S; Volinia S; Greshock J; Lassus H; Hasegawa K; Liang S; Leminen A; Deng S; Smith L; Johnstone CN; Chen XM; Liu CG; Huang Q; Katsaros D; Calin GA; Weber BL; Bützow R; Croce CM; Coukos G; Zhang L
    Cancer Res; 2008 Dec; 68(24):10307-14. PubMed ID: 19074899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.